Your fact-checks will appear here
Tools and methods for assessing the risk of bias in clinical trials
Early of trials began with heterogeneous study pools and inconsistent quality screening, sometimes reporting large positive effects that later proved fragile once problematic trials were removed; in r...
Clinical-trial evidence specifically testing elimination of high‑lectin foods to improve validated markers of intestinal permeability in patients with autoimmune disease is extremely limited: the publ...
No publicly provided trial reports or regulatory documents for were found in the supplied material, so a direct assessment of the quality of evidence for its approved indications is impossible from th...